ChengDu ShengNuo Biotec Co.,Ltd. (SHA:688117)
China · Delayed Price · Currency is CNY 14.21
-0.30 (-2.07%)
Nov 13, 2026, 3:00 PM CST
ChengDu ShengNuo Biotec Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 962.54 | 741.46 | 456.07 | 435.02 | 395.72 | 386.53 |
Revenue Growth | 50.79% | 62.58% | 4.84% | 9.93% | 2.38% | 2.05% |
Gross Profit Gross Profit Growth | 525.17 | 412.59 | 253.23 | 271.64 | 253.33 | 275.86 |
Operating Income Operating Income Growth | 268.83 | 210.63 | 66.06 | 77.27 | 65.04 | 65.71 |
Net Income Net Income Growth | 201.5 | 157.92 | 50.02 | 70.34 | 64.48 | 61.25 |
Earnings Per Share EPS Growth | 0.91 | 0.71 | 0.23 | 0.32 | 0.30 | 0.31 |
EPS Growth | 68.34% | 212.47% | -27.73% | 6.89% | -4.49% | -14.98% |
Fiscal Year | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Preparations Preparations Growth | 196.61 | 189.37 | 176.71 |
Active Pharmaceutical Ingredient (API) Active Pharmaceutical Ingredient (API) Growth | 408.73 | 154.78 | 119.41 |
Pharmaceutical Research Services Pharmaceutical Research Services Growth | 89.68 | 60.92 | 92.33 |
Customized Production Customized Production Growth | 23.33 | 26.24 | 11.09 |
Consignment Processing Services Consignment Processing Services Growth | 0.05 | 19.78 | 31.79 |
Unallocated Others Unallocated Others Growth | 5.59 | 4.78 | 3.7 |
Technology Transfer Technology Transfer Growth | 16.98 | - | - |
Total Total Growth | 740.96 | 455.86 | 435.02 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 318.25 | 301.3 | 238.86 | 269.13 | 372.12 | 411.56 |
Total Debt Total Debt Growth | 676.77 | 589.67 | 482.42 | 261.7 | 102.64 | 32.89 |
Net Cash (Debt) Net Cash Growth | -358.52 | -288.37 | -243.56 | 7.43 | 269.48 | 378.68 |
Net Cash Growth | - | - | - | -97.24% | -28.84% | 192.35% |
Net Cash Per Share Net Cash Per Share Growth | -1.62 | -1.30 | -1.11 | 0.03 | 1.24 | 1.92 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 190.86 | 178.45 | 25.27 | 84.78 | 95.62 | 52.41 |
Capital Expenditures CapEx Growth | -158.6 | -145.77 | -247.48 | -277.98 | -135.85 | -64.22 |
Free Cash Flow Free Cash Flow Growth | 32.26 | 32.68 | -222.2 | -193.2 | -40.23 | -11.81 |
Free Cash Flow Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 54.56% | 55.65% | 55.52% | 62.44% | 64.02% | 71.37% |
Operating Margin | 27.93% | 28.41% | 14.49% | 17.76% | 16.44% | 17.00% |
Pretax Margin | 25.14% | 25.51% | 13.49% | 18.42% | 18.29% | 18.24% |
Profit Margin | 20.94% | 21.30% | 10.97% | 16.17% | 16.30% | 15.85% |
FCF Margin | 3.35% | 4.41% | -48.72% | -44.41% | -10.17% | -3.06% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.251 | 0.251 | 0.071 | 0.102 | 0.091 | 0.109 |
Dividend Per Share Growth | 242.69% | 251.96% | -30.00% | 11.96% | -16.65% | - |
Dividend Yield | 1.77% | 0.93% | 0.55% | 0.71% | 1.13% | 0.82% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 15.73 | 37.66 | 57.69 | 44.90 | 27.57 | 47.82 |
Forward PE | 14.31 | 23.96 | 20.17 | 34.71 | - | - |
P/FCF Ratio | 97.06 | 182.00 | - | - | - | - |
PS Ratio | 3.25 | 8.02 | 6.33 | 7.26 | 4.49 | 7.58 |